Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forbes

Showing results (631-640 of 725) with videos related to

Pageof 73
Sort By:
Circulation Research|March 8, 2003
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changesRiccardo Candido, Josephine M Forbes, Merlin C Thomas, et al.
Experimental Diabetes Research|February 15, 2011
Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathyKarly C Sourris, Brooke E Harcourt, Sally A Penfold, et al.
Diabetes|October 26, 2007
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathwayVicki Thallas-Bonke, Suzanne R Thorpe, Melinda T Coughlan, et al.
Kidney International|May 20, 2003
Reduced tubular cation transport in diabetes: prevented by ACE inhibitionMerlin C Thomas, Chris Tikellis, Wendy C Burns, et al.
Pediatric Radiology|July 17, 2025
Costochondral junction variations in children younger than 2 yearsBoaz Karmazyn, Matthew M Jones, Lisa R Delaney, et al.
World Journal of Urology|April 25, 2025
Burst wave lithotripsy - a paradigm shift: inferences from a scoping reviewSteffi Kar Kei Yuen, Vineet Gauhar, Chu Ann Chai, et al.
Scientific Reports|August 9, 2023
Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetesSherman S Leung, Nataliya Lenchik, Clayton Mathews, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Inflammation and late-life depressive symptomsM Forbes, M Lotfaliany, B Mengist, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)Aowen Zhuang, Felicia Y T Yap, Danielle J Borg, et al.
Pageof 73

Showing results (631-640 of 725) with videos related to

Sort By:
Pageof 73
Circulation Research|March 8, 2003
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changesRiccardo Candido, Josephine M Forbes, Merlin C Thomas, et al.
Experimental Diabetes Research|February 15, 2011
Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathyKarly C Sourris, Brooke E Harcourt, Sally A Penfold, et al.
Diabetes|October 26, 2007
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathwayVicki Thallas-Bonke, Suzanne R Thorpe, Melinda T Coughlan, et al.
Kidney International|May 20, 2003
Reduced tubular cation transport in diabetes: prevented by ACE inhibitionMerlin C Thomas, Chris Tikellis, Wendy C Burns, et al.
Pediatric Radiology|July 17, 2025
Costochondral junction variations in children younger than 2 yearsBoaz Karmazyn, Matthew M Jones, Lisa R Delaney, et al.
World Journal of Urology|April 25, 2025
Burst wave lithotripsy - a paradigm shift: inferences from a scoping reviewSteffi Kar Kei Yuen, Vineet Gauhar, Chu Ann Chai, et al.
Scientific Reports|August 9, 2023
Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetesSherman S Leung, Nataliya Lenchik, Clayton Mathews, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Inflammation and late-life depressive symptomsM Forbes, M Lotfaliany, B Mengist, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)Aowen Zhuang, Felicia Y T Yap, Danielle J Borg, et al.
Pageof 73